United StatesSenate Bill 3716S 3716

Set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.

Last progress January 28, 2026 (1 week ago)

Introduced on January 28, 2026 by Tammy Baldwin

House Votes

Vote Data Not Available

Pending Committee

January 28, 2026 (1 week ago)

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Signature Data Not Available

No AI Summary available yet

No Text Versions

No Amendments